Danielle Rapaccioli

Davis Polk advised the representatives of the underwriters in connection with the $70 million follow-on public offering of 5,000,000 shares of common stock of TransMedics Group, Inc…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a SEC-registered follow-on offering of 4,573,863 shares of common stock…

Davis Polk advised FedEx Corporation on its SEC-registered offering of $1 billion principal amount of 3.800% notes due 2025, $750 million principal amount of 4.250% notes due 2030 and $1.25…

Davis Polk advised PPL Capital Funding, Inc. on its registered offering of $1.0 billion aggregate principal amount of 4.125% senior notes due 2030, fully and unconditionally guaranteed by…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atara Biotherapeutics, Inc. of its common stock for up to an aggregate amount of $100 million. Based in…

Davis Polk advised the joint bookrunners in connection with a primary offering by BR Properties S.A. of common shares for an aggregate amount of R$1.05 billion (approximately US$247.5…

Davis Polk advised the joint bookrunners in connection with the initial public offering by C&A Modas S.A. and the selling shareholders of 98,630,146 common shares for an aggregate…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,303,030 shares of its common stock. The common stock is listed on the…

Davis Polk advised the underwriters in connection with an SEC-registered offering by The Hartford Financial Services Group, Inc. of $600 million aggregate principal amount of its 2.800%…

Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of 6,543,500 shares of common stock of TransMedics Group, Inc.,…